Fuse Medical, Inc.
Fuse Medical, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
Cash | - | 0 | - | 1 | 1 | - | - | 2 | 1 | - | - | 2 | 1 | |||||
Cash And Cash Equivalents At Carrying Value | 0 | - | 0 | - | - | 1 | 1 | - | - | 1 | 1 | - | - | |||||
Accounts Receivable Net Current | 3 | 3 | 4 | 3 | 3 | 2 | 4 | 2 | 3 | 3 | 4 | 3 | 3 | |||||
Assets Current | ||||||||||||||||||
Assets Current | 13 | 12 | 14 | 13 | 13 | 12 | 13 | 13 | 13 | 13 | 13 | 12 | 11 | |||||
Inventory Net | 9 | 9 | 9 | 10 | 9 | 9 | 9 | 9 | 8 | 8 | 7 | 7 | 7 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Long Term Investments And Receivables Net | - | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Property Plant And Equipment Net | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Receivable Net Noncurrent | 3 | - | - | - | - | - | - | - | - | - | - | - | - | |||||
Intangible Assets Net Excluding Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Goodwill | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Assets | 19 | 18 | 20 | 19 | 19 | 18 | 18 | 18 | 18 | 17 | 17 | 17 | 16 | |||||
Liabilities And Stockhold… | ||||||||||||||||||
Accounts Payable Current | 4 | 5 | 6 | 5 | 5 | 5 | 4 | 4 | 4 | 3 | 3 | 2 | 2 | |||||
Liabilities Current | ||||||||||||||||||
Accrued Liabilities Current | 6 | 5 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | |||||
Liabilities Current | 12 | 11 | 12 | 11 | 11 | 10 | 10 | 9 | 8 | 8 | 7 | 7 | 7 | |||||
Notes Payable Related Parties Classified Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Lines Of Credit Current | - | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Notes Payable Related Parties Noncurrent | - | - | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Business Combination Contingent Consideration Liab… | - | 7 | 7 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | |||||
Liabilities Noncurrent | - | - | - | - | - | - | - | 13 | - | - | - | - | - | |||||
Liabilities | 20 | 19 | 20 | 23 | 23 | 22 | 22 | 21 | 20 | 20 | 20 | 19 | 19 | |||||
Preferred Stock Value | 0 | - | - | - | - | - | - | - | - | - | - | - | - | |||||
Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Stockholders Equity | ||||||||||||||||||
Additional Paid In Capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Stockholders Equity | -0 | -1 | -0 | -4 | -4 | -4 | -3 | -3 | -2 | -2 | -2 | -2 | -3 | |||||
Retained Earnings Accumulated Deficit | -2 | -3 | -3 | -6 | -6 | -6 | -6 | -5 | -5 | -4 | -4 | -4 | -4 | |||||
Liabilities And Stockholders Equity | 19 | 18 | 20 | 19 | 19 | 18 | 18 | 18 | 18 | 17 | 17 | 17 | 16 | |||||
Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Inventory Valuation Reserves | 2 | - | - | - | - | - | - | - | - | - | - | - | - | |||||
Allowance For Doubtful Accounts Receivable Noncurr… | 5 | - | - | - | - | - | - | - | - | - | - | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||||
Common Stock Shares Issued | 74 | 74 | 74 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | |||||
Shares Outstanding | 74 | 74 | 74 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 250.00% | 50.00% | 100.00% | 120.00% | 50.00% | 70.00% | - | - | - | - | - | - |
| 2022 | -26.09% | -21.74% | -21.74% | 0.00% | -11.76% | -11.76% | -6.67% | -6.67% | -6.67% | 0.00% | 250.00% | 50.00% |
| 2021 | -5.88% | -5.88% | -5.88% | -17.65% | 129.41% | 323.53% | -13.11% | -29.51% | -63.93% | -25.00% | -64.58% | -66.67% |
| 2020 | - | - | - | - | - | - | 116.67% | 66.67% | 150.00% | 33.33% | 33.33% | 55.56% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | ||||||||||||||||||
| Current Ratio | 1.06 | 1.08 | 1.11 | 1.14 | 1.15 | 1.23 | 1.29 | 1.51 | 1.56 | 1.65 | 1.74 | 1.59 | 1.64 | |||||
| Quick Ratio | 0.31 | 0.26 | 0.33 | 0.27 | 0.32 | 0.28 | 0.41 | 0.50 | 0.54 | 0.64 | 0.77 | 0.64 | 0.60 | |||||
| Working Capital | 754.34K | 954.64K | 1.38M | 1.56M | 1.70M | 2.29M | 2.88M | 4.35M | 4.59M | 4.97M | 5.37M | 4.36M | 4.39M | |||||
Leverage & Debt | ||||||||||||||||||
| Debt to Equity | -84.40 | -35.18 | -64.58 | -5.95 | -5.44 | -5.53 | -6.33 | -6.76 | -8.30 | -8.12 | -9.24 | -8.02 | -7.26 | |||||
| Interest Coverage TTM | 0.69 | -1.27 | -2.02 | -7.90 | -13.19 | -14.20 | -15.54 | -10.59 | -5.79 | -1.13 | -5.19 | -5.69 | -17.84 | |||||
| Debt Ratio | 1.01 | 1.03 | 1.02 | 1.20 | 1.20 | 1.21 | 1.19 | 1.17 | 1.14 | 1.14 | 1.12 | 1.14 | 1.16 | |||||
Efficiency & Turnover | ||||||||||||||||||
| Asset Turnover TTM | 0.96 | 1.00 | 0.98 | 1.07 | 1.05 | 1.17 | 1.14 | 1.22 | 1.33 | 1.26 | 1.20 | 1.24 | 1.17 | |||||
| Days Sales Outstanding TTM | 63.45 | 49.72 | 73.66 | 46.83 | 56.22 | 50.25 | 71.13 | 48.46 | 48.22 | 68.01 | 82.53 | 66.99 | 58.01 | |||||
| Receivables Turnover TTM | 5.75 | 7.34 | 4.95 | 7.79 | 6.49 | 7.26 | 5.13 | 7.53 | 7.57 | 5.37 | 4.42 | 5.45 | 6.29 | |||||
Per Share Metrics | ||||||||||||||||||
| Diluted EPS TTM | 0.05 | 0.05 | 0.04 | - | -0.03 | -0.02 | -0.02 | -0.01 | - | - | -0.02 | -0.00 | - | |||||
| Free Cash Flow Per Share TTM | -0.01 | -0.01 | -0.01 | -0.03 | -0.03 | -0.02 | -0.03 | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | -0.00 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | ||||||||||||||||||
| Gross Profit Margin TTM | 51.94% | 63.88% | 61.90% | 73.71% | 71.38% | 59.24% | 58.47% | 59.10% | 60.97% | 59.60% | 59.37% | 61.07% | 48.38% | |||||
| Operating Profit Margin TTM | 1.49% | -3.00% | -4.37% | -8.90% | -12.75% | -10.74% | -10.75% | -8.63% | -4.62% | -0.99% | -4.80% | -6.37% | -21.17% | |||||
| Net Profit Margin TTM | 21.61% | 18.51% | 16.62% | -5.86% | -9.46% | -7.85% | -7.78% | -4.87% | -1.15% | -2.84% | -6.69% | -1.04% | -20.14% | |||||
Growth Metrics | ||||||||||||||||||
| Net Revenue Growth (1Y) | -5.77% | -11.95% | -8.67% | -7.26% | -14.55% | -3.19% | -4.60% | -1.63% | 5.33% | -6.87% | -6.56% | -7.16% | -11.30% | |||||
| Net Income Growth (1Y) | -315.14% | -307.71% | -295.11% | 11.46% | 600.51% | 167.68% | 10.85% | 360.89% | -93.96% | -85.28% | -56.81% | -117.21% | -177.30% | |||||
| EPS Growth (1Y) | -315.14% | -307.71% | -295.11% | 11.30% | 599.51% | 178.35% | 10.69% | 360.89% | -93.96% | -85.28% | -56.81% | -117.21% | -177.30% | |||||
Valuation Metrics | ||||||||||||||||||
| P/E TTM | 1.06 | 0.63 | 3.40 | -9.09 | -6.85 | -20.95 | -19.04 | -34.39 | -42.58 | -10.94 | -9.31 | -18.65 | -1.45 | |||||
| P/B TTM | -18.22 | -3.91 | -33.93 | -2.72 | -3.00 | -8.67 | -8.81 | -11.45 | -4.56 | -2.69 | -6.31 | -1.74 | -2.43 | |||||
| P/S TTM | 0.23 | 0.12 | 0.57 | 0.53 | 0.65 | 1.64 | 1.48 | 1.68 | 0.49 | 0.31 | 0.62 | 0.19 | 0.29 | |||||
| Market Cap | 4.22M | 2.11M | 10.55M | 10.55M | 12.66M | 33.75M | 30.24M | 35.81M | 11.24M | 6.58M | 13.34M | 4.21M | 6.32M | |||||
| Enterprise Value | 3.97M | 3.63M | 12.40M | 12.09M | 14.29M | 35.14M | 32.12M | 34.96M | 10.79M | 6.25M | 13.07M | 3.71M | 6.24M | |||||
Calculated Values | ||||||||||||||||||
| Free Cash Flow TTM | -502.15K | -649.18K | -624.83K | -1.80M | -1.84M | -1.48M | -1.78M | 5.05K | 364.60K | 368.09K | 215.90K | 525.69K | -206.50K | |||||
| Net Debt | -253.38K | 1.52M | 1.85M | 1.54M | 1.64M | 1.39M | 1.88M | -851.93K | -443.52K | -329.44K | -274.11K | -500.54K | -78.92K | |||||
Per-Share and Margin | ||||||||||||||||||
| EPS TTM | ||||||||||||||||||
| Adjusted EPS TTM | ||||||||||||||||||
| Cash Flow Per Share TTM | ||||||||||||||||||
| Pretax Margin TTM | ||||||||||||||||||
| Stock Comp to Revenue TTM | ||||||||||||||||||
Turnover Ratios and Averages | ||||||||||||||||||
| Average Assets | ||||||||||||||||||
| Average Equity | ||||||||||||||||||
| Average Inventory | ||||||||||||||||||
| Average Receivables | ||||||||||||||||||
| Average Accounts Payables | ||||||||||||||||||
| Inventory Turnover TTM | ||||||||||||||||||
| Payables Turnover TTM | ||||||||||||||||||
| Days Inventory Outstanding TTM | ||||||||||||||||||
| Days Payables Outstanding TTM | ||||||||||||||||||
| Cash Conversion Cycle TTM | ||||||||||||||||||
| Working Capital to Revenue | ||||||||||||||||||
| Deferred Revenue to Revenue | ||||||||||||||||||
Growth Rates | ||||||||||||||||||
| Total Assets Growth (1Y) | ||||||||||||||||||
| Total Assets Growth (3Y) | ||||||||||||||||||
| Total Assets Growth (5Y) | ||||||||||||||||||
| Dividends Paid Growth (1Y) | ||||||||||||||||||
| Dividends Paid Growth (3Y) | ||||||||||||||||||
| Dividends Paid Growth (5Y) | ||||||||||||||||||
| EPS Growth (3Y) | ||||||||||||||||||
| EPS Growth (5Y) | ||||||||||||||||||
| Net Income Growth (3Y) | ||||||||||||||||||
| Net Income Growth (5Y) | ||||||||||||||||||
| Net Profit Margin Growth (1Y) | ||||||||||||||||||
| Net Profit Margin Growth (3Y) | ||||||||||||||||||
| Net Profit Margin Growth (5Y) | ||||||||||||||||||
| Net Revenue Growth (3Y) | ||||||||||||||||||
| Net Revenue Growth (5Y) | ||||||||||||||||||
| Deferred Revenue Growth (1Y) | ||||||||||||||||||
| Retained Earnings Growth (1Y) | ||||||||||||||||||
Credit, Liquidity, Returns, Payout | ||||||||||||||||||
| Cash Ratio | ||||||||||||||||||
| Net Working Capital | ||||||||||||||||||
| Debt to EBITDA TTM | ||||||||||||||||||
| Net Debt to EBITDA TTM | ||||||||||||||||||
| Net Debt to Equity | ||||||||||||||||||
| Altman A | ||||||||||||||||||
| Altman B | ||||||||||||||||||
| Altman C | ||||||||||||||||||
| Altman D | ||||||||||||||||||
| Altman E | ||||||||||||||||||
| Altman Z-Score | ||||||||||||||||||
| ROA TTM | ||||||||||||||||||
| ROE TTM | ||||||||||||||||||
| NOPAT TTM | ||||||||||||||||||
| ROIC TTM | ||||||||||||||||||
| Effective Tax Rate TTM | ||||||||||||||||||
| Payout Ratio TTM | ||||||||||||||||||
| Dilution Ratio | ||||||||||||||||||
| Retained Earnings to Equity | ||||||||||||||||||
| Treasury Stock to Equity | ||||||||||||||||||
| Treasury Stock Change (1Y) | ||||||||||||||||||
| Accrued to Current Liabilities | ||||||||||||||||||
| NCAV | ||||||||||||||||||
| NCAV Per Share TTM | ||||||||||||||||||
Valuation Ratios | ||||||||||||||||||
| P/CF TTM | ||||||||||||||||||
| Dividend Yield TTM | ||||||||||||||||||
| Free Cash Flow Yield TTM | ||||||||||||||||||
| EV EBITDA TTM | ||||||||||||||||||
| EV EBIT TTM | ||||||||||||||||||
| Stock Compensation TTM | ||||||||||||||||||
| Adjusted Net Income TTM | ||||||||||||||||||
| Billings TTM | ||||||||||||||||||
| Total Debt | ||||||||||||||||||
| Invested Capital | ||||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Fuse Medical, Inc. (FZMD) — SEC Financial Statements & Analysis
Fuse Medical, Inc. (FZMD) is a wholesale-medical, dental & hospital equipment & supplies company, incorporated in DE. Fuse Medical, Inc. trades on OTC as: FZMD. Based on its latest SEC filing (Form 10-Q, period ending 2023-06-30), Fuse Medical, Inc. reported a -5.77% year-over-year revenue growth, a Gross Profit Margin of 51.94% (TTM), a Debt-to-Equity ratio of -84.40x, a Price-to-Sales (P/S) ratio of 0.23x (TTM), a Price-to-Book (P/B) ratio of -18.22x (TTM), at a market cap of $4.22M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -5.77%
- Gross Profit Margin TTM
- 51.94%
- Debt To Equity
- -84.40x
- P/S TTM
- 0.23x
- P/B TTM
- -18.22x
- Market Cap
- $4.22M
Data as of 2023-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Fuse Medical, Inc. in?
Fuse Medical, Inc. (FZMD) operates in the Wholesale-Medical, Dental & Hospital Equipment & Supplies industry.
What is FZMD's market cap?
Fuse Medical, Inc. (FZMD) has a market capitalization of $4.22M as of 2023-06-30.
What is FZMD's P/E ratio?
Fuse Medical, Inc. (FZMD)'s trailing twelve month P/E ratio is 1.06x as of 2023-06-30.
What exchange does FZMD trade on?
Fuse Medical, Inc. (FZMD) trades on the OTC.
Where is Fuse Medical, Inc. incorporated?
Fuse Medical, Inc. is incorporated in DE.